Tajiri Resources Corp.
(TAJ-TSXV Profile)
May 20, 2026 Receives C$1 million from warrant exercises and provides update News
May 8, 2026 Issuance of Consideration Shares for Yono Gold Property News

iFabric Corp.
(IFA-TSX Atrium Research)
Jun 5, 2026 Announces Closing of $28 Million Bought Deal Offering News
May 14, 2026 Announces upsize of bought deal treasury and secondary offering News

Norsemont Mining Inc.
(NOM-CSE Profile)
Mar 2, 2026 Targets filing environmental impact declaration in December 2026 News
Feb 24, 2026 Drills 94 meters at 1.26 g/t Au and 109 meters at 1.09 g/t Au both holes starting at surface News

Blue Moon Metals Inc.
(MOON-TSXV Profile)
Feb 27, 2026 To acquire the Apex Germanium and Gallium Mine from Teck to advance US critical mineral projects to secure North American supply News
Feb 11, 2028 Advances four core assets with comprehensive 40,000 meter 2026 infill and step-out drilling programs News

The global blockchain technology is gaining momentum as organization around the globe found the unlimited potential of the technology. It is believed to be one to the hottest sector in coming years. Many research analysts predict the global blockchain technology market to grow at a significant rates...
More about Blockchain Industry >>

  Real Estate Market
The global real estate market size was estimated at USD 4,332.38 billion in 2025 and is projected to reach USD 7,351.30 billion by 2033, growing at a CAGR of 7.1% from 2026 to 2033. The global market is undergoing a structural transformation, driven by urbanization, demographic shifts, and capital reallocation into income-generating assets. Institutional investors continue to scale exposure to... more >>

  Apotex Health Corp.
Apotex Health Corp. is a Canadian-based global health company with a broad portfolio of generic, biosimilar and branded pharmaceuticals, as well as branded consumer health and wellness products. Its portfolio consists of 800+ products (over 300 of which are sold across multiple geographic segments) that cover multiple dosage forms and therapeutic areas across its three business lines include...

IBM combines defensive blue-chip quality with multiple growth drivers. The software business is expanding at a double-digit pace and driving margin expansion, its mainframe refresh cycle is delivering a 51% infrastructure revenue boost, and the company's AI consulting approach is producing $9.5 billion in bookings with predictable ROI for enterprise customers.

Campbell's valuation and income profile are striking. The shares trade at a P/E multiple of just 9.7 times forecast earnings, which is significantly below the broader U.S. market multiple and below many consumer staples peers. Yet the current yield is extremely high for a consumer defensive name and suggests investors are being paid handsomely to wait for operational and sentiment recovery.